These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30148433)

  • 21. Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting.
    Vázquez I; Graell E; Gratacós J; Cañete JD; Viñas O; Ercilla MG; Gómez A; Hernández MV; Rodríguez-Cros JR; Larrosa M; Sanmartí R
    Clin Exp Rheumatol; 2007; 25(2):231-8. PubMed ID: 17543147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.
    Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Christensen R; Ørnbjerg LM; Glinatsi D; Møller JM; Boesen M; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Larsen L; Jurik AG; Thomsen HS; Østergaard M
    Scand J Rheumatol; 2022 Jul; 51(4):268-278. PubMed ID: 34474649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints.
    Picchianti Diamanti A; Navarini L; Messina F; Markovic M; Arcarese L; Basta F; Meneguzzi G; Margiotta DPE; Laganà B; Afeltra A; D'Amelio R; Iagnocco A
    Clin Exp Rheumatol; 2018; 36(6):984-989. PubMed ID: 29998842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables.
    Aramaki T; Kawakami A; Iwamoto N; Fujikawa K; Kawashiri SY; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Nakashima M; Mizokami A; Furuyama M; Matsuoka N; Ueki Y; Ida H; Origuchi T; Aoyagi K; Eguchi K
    Mod Rheumatol; 2009; 19(6):652-6. PubMed ID: 19787419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission.
    Alivernini S; Peluso G; Fedele AL; Tolusso B; Gremese E; Ferraccioli G
    Arthritis Res Ther; 2016 Feb; 18():39. PubMed ID: 26842890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study.
    Glinatsi D; Heiberg MS; Rudin A; Nordström D; Haavardsholm EA; Gudbjornsson B; Østergaard M; Uhlig T; Grondal G; Hørslev-Petersen K; van Vollenhoven R; Hetland ML
    Trials; 2017 Apr; 18(1):161. PubMed ID: 28376912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of ultrasound-detected residual synovitis and risk of relapse and structural progression in rheumatoid arthritis patients in clinical remission: a systematic review and meta-analysis.
    Nguyen H; Ruyssen-Witrand A; Gandjbakhch F; Constantin A; Foltz V; Cantagrel A
    Rheumatology (Oxford); 2014 Nov; 53(11):2110-8. PubMed ID: 24929634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
    Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
    Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort.
    Sewerin P; Vordenbaeumen S; Hoyer A; Brinks R; Buchbender C; Miese F; Schleich C; Klein S; Schneider M; Ostendorf B
    BMC Musculoskelet Disord; 2017 Apr; 18(1):163. PubMed ID: 28420375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and predictors of long-term remission in rheumatoid arthritis in real-world practice: a longitudinal study.
    Khabbazi A; Gadakchi L; Moslemi M; Khalaji A; Esalatmanesh K; Ziarati Yazdeli A; Hajialilo M; Malek Mahdavi A
    Clin Rheumatol; 2023 Jun; 42(6):1537-1544. PubMed ID: 36800137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.
    Ramírez J; Inciarte-Mundo J; Cuervo A; Ruiz-Esquide V; Hernández MV; Sanmartí R; Cañete JD
    Clin Exp Rheumatol; 2017; 35(1):74-79. PubMed ID: 27749227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse.
    Scirè CA; Montecucco C; Codullo V; Epis O; Todoerti M; Caporali R
    Rheumatology (Oxford); 2009 Sep; 48(9):1092-7. PubMed ID: 19561156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study.
    An Y; Liu T; He D; Wu L; Li J; Liu Y; Bi L; Zhou B; Lin C; He L; Liu X; Li X; Yang N; Zhang Z; Song H; Wei W; Liu J; Bi Y; Li Z
    Clin Rheumatol; 2017 Jan; 36(1):35-43. PubMed ID: 27709444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis.
    Lee KE; Choi SE; Xu H; Kang JH; Park DJ; Lee SS
    Rheumatol Int; 2017 Dec; 37(12):2027-2034. PubMed ID: 28956118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.
    Lisbona MP; Solano A; Ares J; Almirall M; Salman-Monte TC; Maymó J
    J Rheumatol; 2016 Sep; 43(9):1631-6. PubMed ID: 27370881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.
    Mäkinen H; Kautiainen H; Hannonen P; Möttönen T; Leirisalo-Repo M; Laasonen L; Korpela M; Blåfield H; Hakola M; Sokka T
    J Rheumatol; 2007 Feb; 34(2):316-21. PubMed ID: 17183623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?
    Ten Cate DF; Jacobs JWG; Swen WAA; Hazes JMW; de Jager MH; Basoski NM; Haagsma CJ; Luime JJ; Gerards AH
    Arthritis Res Ther; 2018 Jan; 20(1):15. PubMed ID: 29382379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial.
    Smolen JS; Szumski A; Koenig AS; Jones TV; Marshall L
    Arthritis Res Ther; 2018 Jan; 20(1):8. PubMed ID: 29338762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs.
    de Moel EC; Rech J; Mahler M; Roth J; Vogl T; Schouffoer A; Goekoop RJ; Huizinga TWJ; Allaart CF; Toes REM; Schett G; van der Woude D
    Arthritis Res Ther; 2019 Dec; 21(1):268. PubMed ID: 31805992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs.
    Montoro Alvarez M; Chong OY; Janta I; González C; López-Longo J; Monteagudo I; Valor L; Garrido J; Lau IS; Rosman A; Naredo E; Carreño L
    Clin Exp Rheumatol; 2015; 33(2):141-5. PubMed ID: 25665178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.